Last deal

$5.M

Amount

Post-IPO Equity

Stage

30.08.2023

Date

11

all rounds

$22.8M

Total amount

General

About Company
NanoVibronix is a medical device company that develops portable devices using its proprietary therapeutic ultrasound technologies.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2003

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

The company's patented technology allows for the creation of miniature transducers that transmit low-frequency, low-intensity ultrasound through flexible materials surfaces, which can be utilized for a variety of medical applications requiring low-cost therapeutic ultrasound qualities. Its primary products, UroShield, PainShield, and WoundShield, employ a small, disposable transducer that transmits low frequency, low intensity ultrasound acoustic waves that seek to repair and regenerate tissue, musculoskeletal and vascular structures, and decrease biofilm formation on urinary catheters and associated urinary tract infections. The company derives revenues from selling its products directly to patients as well as through distributor agreements.
Contacts